Big Pharma

EU publishes proposed drug laws overhaul, setting up tussle with industry
EU publishes proposed drug laws overhaul, setting up tussle with industry
Reuters
Europe
pharma industry
legislation
patients
Big Pharma
Flag link:
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
Flag link:
Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report
Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report
Fierce Biotech
Big Pharma
Novo Nordisk
Moderna Therapeutics
Gilead Sciences
BeiGene
Flag link:
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Flag link:
After pandemic breather, Big Pharma sees drug development costs rise and returns sink: report
After pandemic breather, Big Pharma sees drug development costs rise and returns sink: report
Fierce Biotech
drug development
Big Pharma
Flag link:
When is big pharma no longer big pharma?
When is big pharma no longer big pharma?
EP Vantage
GSK
market cap
Big Pharma
Flag link:
Big Pharma may have to reveal government deals in WHO’s draft pandemic rules
Big Pharma may have to reveal government deals in WHO’s draft pandemic rules
Finance Digest/Reuters
WHO
pandemic
Big Pharma
Flag link:
US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says
US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says
Fierce Pharma
legislation
Inflation Reduction Act
drug pricing
Big Pharma
Joe Biden
credit
Flag link:
Since Biden took over, Big Pharma has spent $205 million to protect drug price status quo, analysis finds
Since Biden took over, Big Pharma has spent $205 million to protect drug price status quo, analysis finds
Fierce Pharma
drug pricing
Joe Biden
Big Pharma
Flag link:
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
Fierce Pharma
earnings
Pfizer
AstraZeneca
Merck
Big Pharma
inflation
supply chain
Ukraine
pandemic
COVID-19
Flag link:
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Pfizer
Gilead Sciences
Big Pharma
ulcerative colitis
Crohn's Disease
drug development
FDA
Flag link:
As Big Pharma loses interest in new antibiotics, infections are only growing stronger
As Big Pharma loses interest in new antibiotics, infections are only growing stronger
Endpoints
antibiotics
antibiotic resistance
UTIs
Big Pharma
Flag link:
Pfizer, Merck, AstraZeneca led Big Pharma's growth in Q1 but they couldn't match mRNA hotshots
Pfizer, Merck, AstraZeneca led Big Pharma's growth in Q1 but they couldn't match mRNA hotshots
Fierce Pharma
Big Pharma
earnings
Pfizer
Merck
AstraZeneca
COVID-19
Moderna Therapeutics
BioNTech
Flag link:
Big pharma’s biggest spenders revealed
Big pharma’s biggest spenders revealed
EP Vantage
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
Flag link:
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Fierce Biotech
regenerative medicine
gene editing
gene therapy
Big Pharma
Intellia Therapeutics
Flag link:
Big Pharma is betting on bigger political ambitions from Sen. Tim Scott
Big Pharma is betting on bigger political ambitions from Sen. Tim Scott
MedCity News
Tim Scott
campaign donations
Big Pharma
Flag link:
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Fierce Pharma
M&A
pharma industry
Big Pharma
JNJ
Pfizer
Moderna Therapeutics
Novartis
BioNTech
GSK
Flag link:
Big Pharma Is Going Holiday Shopping. Who's Next?
Big Pharma Is Going Holiday Shopping. Who's Next?
Motley Fool
Big Pharma
M&A
ChemoCentryx
Epizyme
Magenta Therapeutics
Flag link:
As supply chain worries ease up, Big Pharma CEOs have a new top concern: recruiting and keeping employees
As supply chain worries ease up, Big Pharma CEOs have a new top concern: recruiting and keeping employees
Endpoints
Big Pharma
CEOs
employees employee retention
employee recruitment
Flag link:
Oncology the focus for big pharma catalysts
Oncology the focus for big pharma catalysts
EP Vantage
Big Pharma
cancer
oncology
Merck
Keytruda
AbbVie
Vraylar
Gilead Sciences
Trodelvy
Sanofi
Sarclisa
Novartis
ligelizumab
Flag link:

Pages